Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvoxamine for Long COVID-19 Parosmia
NCT05216614Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluvoxamine in parosmia, sponsored by Washington University School of Medicine. Planned start Dec 2021; status: withdrawn.
02
Drugs
fluvoxamine
03
Conditions
parosmia
Beyond the preview
Go deeper on NCT05216614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05216614.